No Data
No Data
Weight-loss version of semaglutide launched in the Chinese market! novo-nordisk a/s (NVO.US) unlocks new growth engine.
novo-nordisk a/s launched Wegovy in china, with prices lower than in the usa; this is an important step for the company to intensify its investment in the rapidly growing market in china.
Top Gap Ups and Downs on Monday: TSLA, SMCI, LYFT and More
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Top Midday Stories: Spirit Airlines Files for Chapter 11 Bankruptcy Protection; Trump Team Looking to Ease Rules for Self-Driving Cars
European Equities Traded in the US as American Depositary Rise in Monday Trading
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost